Saperconazole
The development of effϊcaceous pharmaceutical compositions of itraconazole and saperconazole is hampered considerably by the fact that said compounds are only very sparingly soluble in water. The solubility of both compounds can be increased by complexation with cyclodextrins or derivatives thereof as described in WO 85/02767 and US-4,764,604.
Unexpectedly, it has now been found that each of the individual stereoisomers of itraconazole and saperconazole have greater water solubility than the diastereomeric mixtures of said compounds, in particular when complexed with cyclodextrin or its derivatives. As a result, pharmaceutical compositions having good bioavailability, yet comprising less cyclodextrin as a complexing agent, can be prepared. The present invention is concemced with the stereoisomeric forms of itraconazole (X = CI) and saperconazole (X = F), which may be represented by the formula
cis-©,and the pharmaceutically acceptable acid addition salt forms thereof. The three asterisks indicate the three chiral centers, and ‘cis’ means that the (lH-l,2,4-triazol-l-ylmethyl) moiety and the substituted phenoxy moiety are located at the same side of the plane defined by the 1,3-dioxolane ring.
The four possible stereoisomeric cis forms can be described using various rules of nomenclature. The following tables show the correlation among the C. A. stereochemical descriptor, the absolute configuration at each of the chiral centers and the specific optical
20 rotation [α]jj in 1% methanol (itraconazole; table I) (saperconazole; table H).
Table I
itraconazole
Table π
saperconazole
| Patent | Submitted | Granted |
|---|---|---|
| ORDERED MESOPOROUS SILICA MATERIAL [US2011081416] | 2010-10-15 | 2011-04-07 |
| BENZOYL PEROXIDE COMPOSITION FOR TREATING SKIN [US2011082216] | 2009-10-02 | 2011-04-07 |
| METHODS RELATED TO TIM 3, A TH1-SPECIFIC CELL SURFACE MOLECULE, FOR ACTIVATING ANTIGEN PRESENTING CELLS [US2015044229] | 2014-08-20 | 2015-02-12 |
| METHODS RELATED TO TIM 3, A TH1-SPECIFIC CELL SURFACE MOLECULE, FOR ACTIVATING ANTIGEN PRESENTING CELLS [US2015044230] | 2014-08-20 | 2015-02-12 |
| COSMETIC METHOD FOR INCREASING COLLAGEN EXPRESSION IN SKIN COMPRISING TOPICALLY APPLYING AN EXTRACT OF QUASSIA AMARA [US2015056310] | 2014-08-20 | 2015-02-26 |
| Flexible bone composite [US8771721] | 2013-03-15 | 2014-07-08 |
| Topical formulation [US8513304] | 2012-11-19 | 2013-08-20 |
| Prolonged release bioadhesive therapeutic systems [US8518442] | 2010-07-02 | 2013-08-27 |
| Preparation method for solid dispersions [US8216495] | 2009-03-25 | 2012-07-10 |
| Flexible bone composite [US8221782] | 2011-08-12 | 2012-07-17 |
| Patent | Submitted | Granted |
|---|---|---|
| Crystalline forms of conazoles and methods of making and using the same [US7446107] | 2005-03-31 | 2008-11-04 |
| CIS-itraconazole crystalline forms and related processes, pharmaceutical compositions and methods [US7078526] | 2004-01-29 | 2006-07-18 |
| Novel Saperconazole Crystalline Forms and Related Processes, Pharmaceutical Compositions and Methods [US2007293674] | 2007-12-20 | |
| NOVEL CRYSTALLINE FORMS OF CONAZOLES AND METHODS OF MAKING AND USING THE SAME [US2009088443] | 2009-04-02 | |
| CONTROLLED RELEASE VEHICLES HAVING DESIRED VOID VOLUME ARCHITECTURES [US2014328884] | 2012-12-17 | 2014-11-06 |
| MOLECULES WITH POTENT DHFR BINDING AFFINITY AND ANTIBACTERIAL ACTIVITY [US2014329840] | 2014-05-05 | 2014-11-06 |
| FUNCTIONALLY-MODIFIED OLIGONUCLEOTIDES AND SUBUNITS THEREOF [US2014330006] | 2012-11-15 | 2014-11-06 |
| ASPARTYL-TRNA SYNTHETASE-FC CONJUGATES [US2014335087] | 2012-12-27 | 2014-11-13 |
| GASTRORETENTIVE CONTROLLED RELEASE VEHICLES THAT INCLUDE ETHYLENE COPOLYMERS, ETHYL CELLULOSES, AND/OR THERMOPLASTIC POLYURETHANES [US2014348936] | 2012-12-17 | 2014-11-27 |
| HISTIDYL-TRNA SYNTHETASE-FC CONJUGATES [US2014349369] | 2014-03-14 | 2014-11-27 |
| ASPARTYL-TRNA SYNTHETASES [US2014302075] | 2012-12-06 | 2014-10-09 |
| Rhinosinusitis Prevention and Therapy with Proinflammatory Cytokine Inhibitors [US2014311482] | 2014-01-24 | 2014-10-23 |
| POLYSACCHARIDE ESTER MICROSPHERES AND METHODS AND ARTICLES RELATING THERETO [US2014315720] | 2014-04-04 | 2014-10-23 |
| MODIFIED GREEN TEA POLYPHENOL FORMULATIONS [US2014256616] | 2014-05-19 | 2014-09-11 |
| PLANT-BASED COMPOSITIONS AND USES THEREOF [US2014260466] | 2013-03-15 | 2014-09-18 |
| PLANT-BASED COMPOSITIONS AND USES THEREOF [US2014271928] | 2014-03-14 | 2014-09-18 |
| LIGHT AND ULTRASONIC TRANSDUCER DEVICE [US2014276247] | 2014-03-14 | 2014-09-18 |
| LIGHT AND/OR ULTRASONIC TRANSDUCER DEVICE WITH SENSOR FEEDBACK FOR DOSE CONTROL [US2014276248] | 2014-03-14 | 2014-09-18 |
| PHOTOPROTECTIVE COMPOSITION CONTAINING AN UNMODIFIED GELLING STARCH AND POLYAMIDE PARTICLES [US2014287005] | 2014-03-18 | 2014-09-25 |
| STABILIZED CHEMICAL DEHYDRATION OF BIOLOGICAL MATERIAL [US2014227686] | 2014-04-16 | 2014-08-14 |
| METHODS RELATED TO TIM 3, A TH1-SPECIFIC CELL SURFACE MOLECULE, FOR ACTIVATING ANTIGEN PRESENTING CELLS [US2014242094] | 2014-02-20 | 2014-08-28 |
| NOVEL ENCOCHLEATION METHODS, COCHLEATES AND METHODS OF USE [US2014242153] | 2014-01-30 | 2014-08-28 |
| METHODS OF REDUCING THE PROLIFERATION AND VIABILITY OF MICROBIAL AGENTS [US2010197621] | 2010-08-05 | |
| METHODS OF ADMINISTERING TOPICAL ANTIFUNGAL FORMULATIONS FOR THE TREATMENT OF FUNGAL INFECTIONS [US2010086504] | 2010-04-08 | |
| COMPOSITIONS AND METHODS FOR INCREASING ERYTHROPOIETIN (EPO) PRODUCTION [US2014024699] | 2011-12-09 | 2014-01-23 |
| PROLONGED RELEASE BIOADHESIVE THERAPEUTIC SYSTEMS [US2013310335] | 2013-07-26 | 2013-11-21 |
| Pharmaceutical Composition [US2013315988] | 2011-05-23 | 2013-11-28 |
| Topical Foam Composition [US2013315998] | 2013-08-05 | 2013-11-28 |
| ANTIFUNGAL NAIL COAT AND METHOD OF USE [US2013323189] | 2013-08-09 | 2013-12-05 |
| TOPICAL FORMULATIONS, SYSTEMS AND METHODS [US2013337031] | 2013-03-08 | 2013-12-19 |
Filed under: Uncategorized Tagged: Saperconazole
